Navigation Links
ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
Date:5/26/2009

HALIFAX, NS, May 26 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based, clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech's GTU(R) MultiHIV DNA plasmid with IVT's DepoVax(TM) vaccine delivery system to advance a therapeutic HIV vaccine.

"DepoVax(TM) will act as a vector to deliver FIT Biotech's GTU(R) MultiHIV DNA vaccine and our goal is to develop a more sophisticated and efficient HIV vaccine candidate," commented Dr. Marc Mansour, Vice President R&D at IVT.

The development of an HIV vaccine is complicated by the ability of the virus to mutate rapidly. FIT Biotech has addressed this challenge by designing a synthetic DNA plasmid, known as GTU(R) MultiHIV that covers the antigenic variability within HIV strains. GTU(R) MultiHIV and is comprised of the multi-epitope/multivalent HIV antigens. As FIT Biotech's lead vaccine candidate, GTU(R) MultiHIV has the potential to trigger an immune response that slows the progression of HIV in infected individuals.

IVT's pre-clinical research demonstrates that DepoVax(TM) effectively delivers DNA plasmids into draining lymph nodes with as little as one dose. The DepoVax(TM) platform uses liposomes to encapsulate a target antigen, like GTU(R) MultiHIV, and adjuvant. DepoVax(TM) also relies on a hydrophobic carrier to create a depot effect that significantly enhances vaccine induced cell-mediated and humoral immunity.

This pre-clinical research partnership will combine the complementary technologies of DepoVax(TM) and GTU(R) MultiHIV. Both IVT and FIT Biotech will examine the novel vaccine's capabilities of inducing cell-mediated and humoral immunity against HIV virus.

"By testing DepoVax(TM) in combination with GTU(R) MultiHIV plasmid, we are working towards developing a superior vaccine candidate for therapeutic use against HIV a
'/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
2. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
3. ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
4. ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PAs Best 50 Women in Business
5. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
6. ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
7. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
8. ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canadas Ability to Deal with Biological Threats
9. ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imagin
10. ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: A...aceutical company focused on endocrine therapy and...Drug Administration (FDA) has granted Fast Track d...bitor compound, perifosine (KRX-0401), for the tre...ryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is...
(Date:12/1/2009)... PDL BioPharma, Inc. (PD...ce for the fourth quarter ended December 31, 2009 ... million for the fourth quarter of 2008. Included ...o installment payments of $12.5 million from Alexi...was a one-time $1.8 million payment from Genentech...
(Date:12/1/2009).... 1 To address the emergence of th...tential, a group of individuals and companies anno...try Association (SynBIA) in Cambridge, Massachuset...ovide a forum for individuals and commercial inter...rtunities and its challenges, and advocate for its...
(Date:12/1/2009)...swire/ -- The Burrill Biotech Select Index managed...ober. The Select,s gain of 4.5 percent mirrored wh...kets with the Dow up 6.5 percent and the NASDAQ up...final two trading days of the month despite invest...pping and Dubai,s reported debt woes. ,, Almost...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
... Velcura Therapeutics, Inc.,has named Jeffrey N. ...,more than 20 years of successful regulatory exper...elcura Therapeutics President and CEO Michael W. L...nior management team. He will be,responsible for o...ance and,interactions with the Federal Drug Admini...
...ampbell Alliance, the leading,management consultin...ech,industries, announced today that it has launch... practice will help clients develop strategies and...stribution, maximize the,effectiveness of trade pr...specialty pharmacies. Campbell Alliance is organi...
...ssachusetts, October 15 /PRNewswire-FirstCall/,-- ...t this week,s American,Society of Anesthesiologist...lution Microstream(R) Monitoring System (MSM(TM)),...e MSM system, a wireless technology for,continuous...egrated,ventilation and oxygenation remote patient...
Other Biology Technology:Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs 2Campbell Alliance Launches New Practice Area Focused on Trade and Distribution 2Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety 2Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety 3Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety 4
(Date:12/2/2009)...ke for a prolonged period of time and in high quan...in women who never smoked cigarettes themselves. ...am smoke could increase risk of breast cancer is o..., senior research scientist at the Northern Califo...ngle epidemiologic study can answer the question, ...
(Date:12/2/2009)... other foods have done more than raise public awar... quietly fueling a boom in the market for food tes...ations. That,s the topic of the two-part cover sto... News , (C&EN) ACS, weekly newsmagazine. , C&EN ...pondent Marc Reisch point out that food safety is ...
(Date:12/2/2009)... researchers have figured out how stem cells in th... to resist radiation therapy. And using a drug to ...er stem cells, they were able to kill many more gl...nt. , The work builds off earlier research whic... of radiation much better than other cancer cells....
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Discovery makes brain tumor cells more responsive to radiation 2Queens scientists on international team discover ecologically unique changes in Arctic lake 10452 1Queens scientists on international team discover ecologically unique changes in Arctic lake 10452 2Finding the ASX200 for marine ecosystems 10449 1Finding the ASX200 for marine ecosystems 10449 2Smallest nanoantennas for high speed data networks 14552 1Smallest nanoantennas for high speed data networks 14552 2Smallest nanoantennas for high speed data networks 14552 3
...human autoimmune disorders and other diseases work...olved in energy production, University of Michigan...unction of enzymes, essentially turning them off,"...llegiate Professor of Chemistry at U-M. "Our compo...e to dial enzyme activity down to a level that mai...
...tion competition, Dr Frederic Meunier, is developi...modifying botox –the popular anti-wrinkle treatmen...f the nerve pathways controlling muscle activity. ...g disorders which lead toprogressive weakness and ...able. , Dr Meunier is developing botox to selecti...
...edicine of Yeshiva University have observed for th... form of discrete "pulses" of gene activity. The r...developed by Dr. Robert Singer and colleagues at E...to directly watch the behavior of a single gene in... issue of Current Biology. , When a gene is expres...
Other Biology News:Drug dials down the energy within cells, UM researchers find 2Einstein researchers take the pulse of a gene in living cells 2
Rabbit Anti-oligophrenin-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Anti-VEGF Receptor-2 (FLK-1, KDR), phospho (Tyr996) Antibody, Unconjugated from CHEMICON
T7Select1-1 OrientExpress cDNA Cloning System Random Primer from Novagen
Goat Anti-Bag-1 (K-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: